Cleared Traditional

K970853 - PATHFINDER 3MM MAPPING MICROCATHETER (01-082001)

K970853 is an FDA 510(k) clearance for PATHFINDER 3MM MAPPING MICROCATHETER (0..., manufactured by Cardima, Inc.. The device is a Class 2 Cardiovascular device with product code DRF cleared through the Traditional 510(k) pathway after a 242-day FDA review.

K970853 · Cardima, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1997
Decision
242d
Days
Class 2
Risk

K970853 is an FDA 510(k) clearance for the PATHFINDER 3MM MAPPING MICROCATHETER (01-082001). Classified as Catheter, Electrode Recording, Or Probe, Electrode Recording (product code DRF), Class II - Special Controls.

Submitted by Cardima, Inc. (Fremont, US). The FDA issued a Cleared decision on November 4, 1997 after a review of 242 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1220 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Cardima, Inc. devices

FDA 510(k) Submission Details - K970853

510(k) Number K970853 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 07, 1997
Decision Date November 04, 1997
Days to Decision 242 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
117d slower than avg
Panel avg: 125d · This submission: 242d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRF Device Classification - Class 2, Special Controls

Product Code DRF Catheter, Electrode Recording, Or Probe, Electrode Recording
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRF Catheter, Electrode Recording, Or Probe, Electrode Recording

All 111
Devices cleared under the same product code (DRF) and FDA review panel - the closest regulatory comparables to K970853.
CORDIS WEBSTER REF-STAR EX SURFACE REFERENCE DEVICE MODEL'S D-1204-01, -02,-03, AND -04.
K980961 · Cordis Webster, Inc. · May 1998
HEXAPOLAR ELECTRODE BALLOON FLOTATION CATHETER
K971504 · J-Lloyd Medical, Inc. · Apr 1998
ELECTRODE SEMI-FLOTATION CATHETER BY J-LLOYD MEDICAL, INC.
K973639 · J-Lloyd Medical, Inc. · Apr 1998
VIKING DIAGNOSTIC ELECTRODE CATHETER
K971265 · C.R. Bard, Inc. · Oct 1997
ARRHYTHMIA MAPPING SYSTEM (8100/8300)
K965066 · Cardiac Pathways Corp. · Aug 1997
ELECTRODE RECORDING CATHETER
K954651 · Boston Scientific Corp · Oct 1996